Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04554927 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Study acronym: WEBAPPAC
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Site details revised
    v7
  2. Primary completion date changed from estimate of Nov 2024 to Oct 11, 2024
    • Study completion date: Mar 3, 2025 to Dec 31, 2025
    v6
  3. Primary completion date: Sep 3, 2023 to Nov 2024v5
  4. Primary completion date: Sep 3, 2022 to Sep 3, 2023v4
  5. Primary completion date: Mar 3, 2022 to Sep 3, 2022
    • Study completion date: Sep 3, 2024 to Mar 3, 2025
    v3
  6. Secondary endpoints: 1 to 2v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.
Trial Details
NCT Number NCT04554927
Lead Sponsor Centre Francois Baclesse
Conditions
(from sponsor)		 Web-application, Breast Cancer, Hormono Therapy
Related terms Breast Neoplasms
Enrollment 438 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov